Active Ingredient(s):Atovaquone + Proguanil FDA Approved: * July 14, 2000 Pharm Company: *GLAXOSMITHKLINE Category:Malaria
Atovaquone/proguanil, sold under the brand name Malarone among others, is a fixed-dose combination medication used to treat and prevent malaria, including chloroquine-resistant malaria. It contains atovaquone and proguanil. It is not recommended for severe or complicated malaria. It is taken by mouth.
Common side effects include abdominal pain, vomiting, diarrhea, cough, and itchiness.[2&...
* May have multiple approval dates, manufacturers, or labelers. 6 Discussions